Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 7(1): 4153, 2017 06 23.
Artigo em Inglês | MEDLINE | ID: mdl-28646200

RESUMO

Mesenchymal stem cells (MSCs) have been used for cell-based therapies in regenerative medicine, with increasing importance in central and peripheral nervous system repair. However, MSCs grafting present disadvantages, such as, a high number of cells required for transplantation and low survival rate when transplanted into the central nervous system (CNS). In line with this, MSCs secretome which present on its composition a wide range of molecules (neurotrophins, cytokines) and microvesicles, can be a solution to surpass these problems. However, the effect of MSCs secretome in axonal elongation is poorly understood. In this study, we demonstrate that application of MSCs secretome to both rat cortical and hippocampal neurons induces an increase in axonal length. In addition, we show that this growth effect is axonal intrinsic with no contribution from the cell body. To further understand which are the molecules required for secretome-induced axonal outgrowth effect, we depleted brain-derived neurotrophic factor (BDNF) from the secretome. Our results show that in the absence of BDNF, secretome-induced axonal elongation effect is lost and that axons present a reduced axonal growth rate. Altogether, our results demonstrate that MSCs secretome is able to promote axonal outgrowth in CNS neurons and this effect is mediated by BDNF.


Assuntos
Fator Neurotrófico Derivado do Encéfalo/metabolismo , Células-Tronco Mesenquimais/metabolismo , Crescimento Neuronal , Proteoma/metabolismo , Animais , Sistema Nervoso Central/citologia , Meios de Cultivo Condicionados/farmacologia , Humanos , Células-Tronco Mesenquimais/efeitos dos fármacos , Microfluídica , Modelos Neurológicos , Crescimento Neuronal/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Ratos Wistar , Receptor trkB/metabolismo , Cordão Umbilical/irrigação sanguínea , Cordão Umbilical/citologia
2.
Neurobiol Aging ; 33(4): 824.e5-16, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21704433

RESUMO

Previously we reported that endoplasmic reticulum (ER)-mitochondria crosstalk is involved in amyloid-ß (Aß)-induced apoptosis. Now we show that mitochondrial dysfunction affects the ER stress response triggered by Aß using cybrids that recreate the defect in mitochondrial cytochrome c oxidase (COX) activity detected in platelets from Alzheimer's disease (AD) patients. AD and control cybrids were treated with Aß or classical ER stressors and the ER stress-mediated apoptotic cell death pathway was accessed. Upon treatment, we found increased glucose-regulated protein 78 (GRP78) levels and caspase-4 activation (ER stress markers) which were more pronounced in AD cybrids. Treated AD cybrids also exhibited decreased cell survival as well as increased caspase-3-like activity, poli-ADP-ribose-polymerase (PARP) levels and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive apoptotic cells. Finally, we showed that Aß-induced caspase-3 activation in both cybrid cell lines was prevented by dantrolene, thus implicating ER Ca(2+) release in ER stress-mediated apoptosis. Our results demonstrate that mitochondrial dysfunction occurring in AD patients due to COX inhibition potentiates cell susceptibility to Aß-induced ER stress. This study further supports the close communication between ER and mitochondria during apoptosis in AD.


Assuntos
Peptídeos beta-Amiloides/farmacologia , Retículo Endoplasmático/efeitos dos fármacos , Células Híbridas/ultraestrutura , Mitocôndrias/fisiologia , Fragmentos de Peptídeos/farmacologia , Idoso , Doença de Alzheimer/sangue , Doença de Alzheimer/patologia , Análise de Variância , Plaquetas/citologia , Brefeldina A/farmacologia , Caspase 3/metabolismo , Morte Celular/efeitos dos fármacos , Fusão Celular/métodos , Linhagem Celular Tumoral/patologia , Chaperona BiP do Retículo Endoplasmático , Feminino , Regulação da Expressão Gênica/efeitos dos fármacos , Proteínas de Choque Térmico/metabolismo , Humanos , Células Híbridas/efeitos dos fármacos , Marcação In Situ das Extremidades Cortadas , Masculino , Pessoa de Meia-Idade , Mitocôndrias/efeitos dos fármacos , Poli(ADP-Ribose) Polimerases/metabolismo , Inibidores da Síntese de Proteínas/farmacologia , Sais de Tetrazólio , Tapsigargina/farmacologia , Tiazóis
3.
J Alzheimers Dis ; 20(2): 625-36, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20182029

RESUMO

Amyloid-beta (Abeta) peptide plays a significant role in the pathogenesis of Alzheimer's disease (AD). Previously we found that Abeta induces both mitochondrial and endoplasmic reticulum (ER) dysfunction leading to apoptosis, and now we address the relevance of ER-mitochondria crosstalk in apoptotic cell death triggered by Abeta peptide. Using mitochondrial DNA-depleted rho0 cells derived from the human NT2 teratocarcinoma cell line, characterized by the absence of functional mitochondria, and the parental rho+ cells, we report here that treatment with the synthetic Abeta1-40 peptide, or the classical ER stressors thapsigargin or brefeldin A, increases GRP78 expression levels and caspase activity, two ER stress markers, and also depletes ER calcium stores. Significantly, we show that the presence of functional mitochondria is required for ER stress-mediated apoptotic cell death triggered by toxic insults such as Abeta. We found that the increase in the levels of the pro-apoptotic transcription factor GADD153/CHOP, which mediates ER stress-induced cell death, as well as caspase-9 and -3 activation and increased number of TUNEL-positive cells, occurs in treated parental rho+ cells but is abolished in rho0 cells. Our results strongly support the close communication between ER and mitochondria during apoptotic cell death induced by the Abeta peptide and provide insights into the molecular cascade of cell death in AD.


Assuntos
Peptídeos beta-Amiloides/farmacologia , Apoptose/efeitos dos fármacos , Retículo Endoplasmático/efeitos dos fármacos , Mitocôndrias/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Fragmentos de Peptídeos/farmacologia , Análise de Variância , Brefeldina A/farmacologia , Caspases/metabolismo , Linhagem Celular Tumoral , Chaperona BiP do Retículo Endoplasmático , Humanos , Marcação In Situ das Extremidades Cortadas/métodos , Inibidores da Síntese de Proteínas/farmacologia , Teratocarcinoma/patologia , Teratocarcinoma/ultraestrutura , Tapsigargina/farmacologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA